» Articles » PMID: 18948752

Fbxw7 in Cell Cycle Exit and Stem Cell Maintenance: Insight from Gene-targeted Mice

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2008 Oct 25
PMID 18948752
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Regulation of the exit of cells from the cell cycle is important in the development of multicellular organisms and is also implicated in the maintenance of stem cells. Furthermore, defects in cell cycle exit are thought to be a major cause of cancer. However, the mechanisms responsible for regulation of cell cycle exit have remained largely unknown. Fbxw7 is the F-box protein subunit of an SCF-type ubiquitin ligase complex that targets positive regulators of the cell cycle-including cyclin E, c-Myc, Notch and c-Jun-for ubiquitylation and subsequent degradation by the 26S proteasome in order to promote cell cycle exit. Consistent with such a function, mutations of the Fbxw7 gene have been detected in various human malignancies. We have recently generated conventional and conditional Fbxw7 knockout mice and examined stem cells, progenitor cells and differentiated cells in the mutant animals for cell cycle defects. Here we summarize the pleiotropic phenotypes of Fbxw7 deficiency in various cell types including T cells, hematopoietic stem cells and embryonic fibroblasts. Such phenotypes have provided insight into the biological roles of Fbxw7 in cell cycle exit, stem cell maintenance and oncosuppression.

Citing Articles

Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies.

Yang S, Seo J, Choi J, Kim S, Kuk Y, Park K Mol Cancer. 2025; 24(1):47.

PMID: 39953555 PMC: 11829473. DOI: 10.1186/s12943-025-02250-9.


Impact of G1 phase kinetics on the acquisition of stemness in cancer cells: the critical role of cyclin D.

Ahmadi Y, Faiq T, Abolhasani S Mol Biol Rep. 2025; 52(1):230.

PMID: 39951181 DOI: 10.1007/s11033-025-10351-3.


FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies.

Wang W, Jiang K, Liu X, Li J, Zhou W, Wang C Front Pharmacol. 2023; 14:1278056.

PMID: 38027013 PMC: 10680170. DOI: 10.3389/fphar.2023.1278056.


The significance of CDT1 expression in non-cancerous and cancerous liver in cases with hepatocellular carcinoma.

Ogawa M, Moriyama M, Midorikawa Y, Nakamura H, Shibata T, Kuroda K J Clin Biochem Nutr. 2023; 73(3):234-248.

PMID: 37970553 PMC: 10636575. DOI: 10.3164/jcbn.23-43.


The genomic regulation of metastatic dormancy.

Gelman I Cancer Metastasis Rev. 2023; 42(1):255-276.

PMID: 36600151 PMC: 10231431. DOI: 10.1007/s10555-022-10076-w.